Advanced search

You are trying to reach document intended for healthcare professionals only

Letters to HCPs

{pdf_link}

Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity

{healthcare_pro_orange} For Healthcare Professionals
Direct Healthcare Professional Communication regarding 5-Fluorouracil (i.v.), Capecitabine and Tegafur containing products - Pre-treatment testing to identify DPD-deficient patients at increased risk of severe and fatal toxicity

Are you a healthcare professional?